MENU
ENSC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ensysce Biosciences (ENSC) Ownership - Who owns Ensysce Biosciences?

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs... Show more

Profile

Industry
N/A
Address
7946 Ivanhoe Avenue
Phone
+1 858 263-4196
Employees
9
Web
https://www.ensysce.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.38M
P/E Ratio
0.02
Total Cash
1.67M
Projected Growth
N/A
Total Debt
387.7K
Revenue
N/A
Risk (Beta)
1.70
Dividend Yield
N/A
Total Cash/Share
0.46
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ENSC
Capitalization
3.38M
P/E Ratio
0.02
Risk (Beta)
1.70
Dividend Yield
N/A
Total Cash
1.67M
Total Cash/Share
0.46
Total Debt
388K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.2M
P/B Ratio
2.81
Cash Flow
N/A
Earnings
-6.35
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
320
Current Ratio
1.27
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-10.95M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-174.66
Shares Held By Institutions
767K
Shares Outstanding - Current
3.63M
Total Liabilities
2.31M
Total Volume MTD
N/A
Value
1
Gain YTD
1.087
View a ticker or compare two or three
ENSC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7946 Ivanhoe Avenue
Phone
+1 858 263-4196
Employees
9
Web
https://www.ensysce.com